Reproductive and Developmental Biology

The Korean Society of Animal Reproduction (한국동물번식학회)
권호 표지

Functional Expression of Saccharomyces cerevisiae NADH-quinone Oxidoreductase (NDI1) Gene in the AML12 Mouse Liver Hepatocytes for the Applying Embryonic Stem Cell

  • Seo, Byoung-Boo (Dept. of Animal Resources, College of Life & Environmental Science, Daegu University) ;
  • Park, Hum-Dai (Dept. of Biotechnology, College of Engineering, Daegu University)
  • Received : 2011.11.01
  • Accepted : 2011.06.11
  • Published : 2011.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Mitochondria diseases have been reported to involve structural and functional defects of complex I-V. Especially, many of these diseases are known to be related to dysfunction of mitochondrial proton-translocating NADH-ubiquinone oxidoreductase (complex I). The dysfunction of mitochondria complex I is associated with neurodegenerative disorders, such as Parkinson's disease, Huntington's disease, and Leber's hereditary optic neuropathy (LHON). Mammalian mitochondrial proton-translocating NADH-quinone oxidoreductase (complex I) is largest and consists of at least 46 different subunits. In contrast, the NDI1 gene of Saccharomyces cerevisiae is a single subunit rotenone-insensitive NADH-quinone oxidoreductase that is located on the matrix side of the inner mitochondrial membrane. The Saccharomyces cerevisiae NDI1 gene using a recombinant adeno-associated virus vector (rAAV-NDI1) was successfully expressed in AML12 mouse liver hepatocytes and the NDI1-transduced cells were able to grow in media containing rotenone. In contrast, control cells that did not receive the NDI1 gene failed to survive. The expressed Ndi1 enzyme was recognized to be localized in mitochondria by confocal immunofluorescence microscopic analyses and immunoblotting. Using digitonin-permeabilized cells, it was shown that the NADH oxidase activity of the NDI1-transduced cells was not affected by rotenone which is inhibitor of complex I, but was inhibited by antimycin A. Furthermore, these results indicate that Ndi1 can be functionally expressed in the AML12 mouse liver hepatocytes. It is conceivable that the NDI1 gene is powerful tool for gene therapy of mitochondrial diseases caused by complex I deficiency. In the future, we will attempt to functionally express the NDI1 gene in mouse embryonic stem (mES) cell.

Keywords

References

  1. Au HC, Seo BB, Matsuno-Yagi A, Yagi T, Scheffler IE (1999): The NDUFA1 gene product (MWFE protein) is essential for activity of complex I in mammalian mitochondria. Proc Natl Acad Sci USA 96:4354-4359. https://doi.org/10.1073/pnas.96.8.4354
  2. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000): Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3:1301-1306. https://doi.org/10.1038/81834
  3. Buchanan SK, Walker JE (1996): Large-scale chromatographic purification of F1F0-ATPase and complex I from bovine heart mitochondria. Biochem J 318:343- 349. https://doi.org/10.1042/bj3180343
  4. Burger C, Nash K, Mandel RJ (2005): Recombinant adeno-associated viral vectors in the nervous system. Hum Gene Ther 16(7):781-91. https://doi.org/10.1089/hum.2005.16.781
  5. Chomyn A, Mariottini P, Cleeter MWJ, Ragan CI, Matsuno- Yagi A, Hatefi Y, Doolittle RF, Attardi G (1985): Six unidentified reading frames of human mitochondrial DNA encode components of the respiratory-chain NADH dehydrogenase. Nature 314:591-597.
  6. Chomyn A, Cleeter MWJ, Ragan CI, Riley M, Doolittle RF, Attardi G (1986): URF6, last unidentified reading frame of human mtDNA, codes for an NADH dehydrogenase subunit. Science 234:614-618. https://doi.org/10.1126/science.3764430
  7. Dawson TM, Dawson VL (2003): Molecular pathways of neurodegeneration in Parkinson's disease. Science 302:819-822. https://doi.org/10.1126/science.1087753
  8. De Francesco L, Scheffler IE, Bissell M (1976): A respiration- deficient Chinese hamster cell line with a defect in NADH-coenzyme Q reductase. J Biol Chem 251: 4588-4595.
  9. de Vries S, Grivell LA (1988): Purification and characterization of a rotenone-insensitive NADH-Q6 oxidoreductase from mitochondria of Saccharomyces cerevisiae. Eur J Biochem 176:377-384. https://doi.org/10.1111/j.1432-1033.1988.tb14292.x
  10. de Vries S, Van Witzenburg R, Grivell LA, Marres CAM (1992): Primary structure and import pathway of the rotenone-insensitive NADH-ubiquinone oxidoreductase of mitochondria from Saccharomyces cerevisiae. Eur J Biochem 203:587-592. https://doi.org/10.1111/j.1432-1033.1992.tb16587.x
  11. Flotte TR, Afione SA, Conrad C, McGrath SA, Solow R, Oka H, Zeitlin PL, Guggino WB, Carter BJ (1993): Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci USA 90:10613-10617. https://doi.org/10.1073/pnas.90.22.10613
  12. Granger DL, Lehninger AL (1982): Sites of inhibition of mitochondrial electron transport in macrophage- injured neoplastic cells. J Cell Biol 95: 527- 535. https://doi.org/10.1083/jcb.95.2.527
  13. Guy J, Qi X, Pallotti F, Schon EA, Manfredi G, Carelli V, Martinuzzi A, Hauswirth WW, Lewin AS (2002): Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy. Ann Neurol 52: 534-542. https://doi.org/10.1002/ana.10354
  14. Hatefi Y (1985): The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem 54:1015-1069. https://doi.org/10.1146/annurev.bi.54.070185.005055
  15. Hofhaus G, Shakeley RM, Attardi G (1996): Use of polarography to detect respiration defects in cell cultures. Methods Enzymol 264:476-483.
  16. Kitajima-Ihara T, Yagi T (1998): Rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria: the enzyme expressed in Escherichia coli acts as a member of the respiratory chain in the host cells. FEBS Lett 421:37-40. https://doi.org/10.1016/S0014-5793(97)01533-0
  17. Klimatcheva E, Rosenblatt JD, Planelles V (1999): Lentiviral vectors and gene therapy. Front Biosci 4:D- 481-D496. https://doi.org/10.2741/Klimatcheva
  18. Laemmli UK (1970): Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685. https://doi.org/10.1038/227680a0
  19. Luft R (1994): The development of mitochondrial medicine. Proc Natl Acad Sci USA 91(19):8731-8. https://doi.org/10.1073/pnas.91.19.8731
  20. Manfredi G, Fu J, Ojaimi J, Sadlock JE, Kwong JQ, Guy J, Schon EA (2002): Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus. Nat Genet 30:394-399. https://doi.org/10.1038/ng851
  21. Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA (2002): The herbicide paraquat causes up-regulation and aggregation of $\alpha$-synuclein in mice: paraquat and $\alpha$-synuclein. J Biol Chem 277:1641-1644. https://doi.org/10.1074/jbc.C100560200
  22. Marres CAM, de Vries S, Grivell LA (1991): Isolation and inactivation of the nuclear gene encoding the rotenone-insensitive internal NADH: ubiquinone oxidoreductase of mitochondria from Saccharomyce cerevisiae. Eur J Biochem 195:857-862. https://doi.org/10.1111/j.1432-1033.1991.tb15775.x
  23. Marella M, Seo BB, Flotte TR, Matsuno-Yagi A, Yagi T (2011): No immune responses by the expression of the yeast ndi1 protein in rats. PLoS One 6(10):e25910 https://doi.org/10.1371/journal.pone.0025910
  24. Muzyczka N (1994): Adeno-associated virus (AAV) vectors: will they work? J Clin Invest 94:1351. https://doi.org/10.1172/JCI117468
  25. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D (1996): In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267. https://doi.org/10.1126/science.272.5259.263
  26. Nesnow S, Grindstaff RD, Lambert G, Padgett WT, Bruno M, Ge Y, Chen PJ, Wood CE, Murphy L (2011): Propiconazole increases reactive oxygen species levels in mouse hepatic cells in culture and in mouse liver by a cytochrome P450 enzyme mediated process. Chem Biol Interact 194 (1):79-89. https://doi.org/10.1016/j.cbi.2011.08.002
  27. Robbins PD, Ghivizzani SC (1998): Viral vectors for gene therapy. Pharmacol Ther 80:35-47. https://doi.org/10.1016/S0163-7258(98)00020-5
  28. Sherer TB, Betarbet R, Greenamyre JT (2002): Environment, mitochondria, and Parkinson's disease. Neuroscientist 8:192-197.
  29. Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A, Greenamyre JT (2003): Mechanism of toxicity in rotenone models of Parkinson's disease. J Neurosci 23:10756-10764.
  30. Shoffner JM, Wallace DC (1994): Oxidative phosphorylation diseases and mitochondrial DNA mutations diagnosis and treatment. Rev Nutr 14:535-568. https://doi.org/10.1146/annurev.nu.14.070194.002535
  31. Seo BB, Kitajima-Ihara T, Chan EK, Scheffler IE, Matsuno- Yagi A, Yagi T (1998): Molecular remedy of complex I defects: Rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria restores the NADH oxidase activity of complex I-deficient mammalian cells. Proc Natl Acad Sci USA 95:9167-9171. https://doi.org/10.1073/pnas.95.16.9167
  32. Seo BB, Matsuno-Yagi A, Yagi T (1999): Modulation of oxidative phosphorylation of human kidney 293 cells by transfection with the internal rotenone-insensitive NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae. Biochim Biophys Acta 1412:56-65. https://doi.org/10.1016/S0005-2728(99)00051-1
  33. Seo BB, Wang J, Flotte TR, Yagi T, Matsuno-Yagi A (2000): Use of the NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae as a possible cure for complex I defects in human cells. J Biol Chem 275:37774-37778. https://doi.org/10.1074/jbc.M007033200
  34. Singer DR, Sagnella GA, Markandu ND, Buckley MG, MacGregor GA (1987): Atrial natriuretic peptide, blood pressure, and age. Lancet 2:1394-1395.
  35. Todd S, Anderson C, Jolly DJ, Craik CS (2000): HIV protease as a target for retrovirus vector-mediated gene therapy. Biochim Biophys Acta 1477:168-188. https://doi.org/10.1016/S0167-4838(99)00272-1
  36. Trounce IA, Kim YL, Jun AS, Wallace DC (1996): Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Method Enzymol 264: 484-509.
  37. Wallace DC (1992): Diseases of the mitochondrial DNA. Annu Rev Biochem 61:1175-1212. https://doi.org/10.1146/annurev.bi.61.070192.005523
  38. Wallace DC, Shoffner JM, Watts RL, Juncos JL, Torroni A (1992): Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann Neurol 32: 113-114. https://doi.org/10.1002/ana.410320123
  39. Wallace DC (1993): Mitochondrial diseases: genotype versus phenotype. Trends Genet 9(4):128-33. https://doi.org/10.1016/0168-9525(93)90207-X
  40. Wu N, Ataai MM (2000): Production of viral vectors for gene therapy applications. Curr Opin Biotechnol 11:205-208. https://doi.org/10.1016/S0958-1669(00)00080-X
  41. Yagi T (1993): The bacterial energy-transducing NADH- quinone oxidoreductases. Biochim Biophys Acta 1141:1-17. https://doi.org/10.1016/0005-2728(93)90182-F